INS and type 2 diabetes mellitus: We identified 1 601 334 patients (mean [SD] age, 62.5 [14.4] years; 751 026 female [46.9%]) with T2D, of whom 51 617 received exclusively GLP-1RA, 611 115 received metformin, and 938 602 received insulin (Table 1).